Physician profile
Kamil J Bober
NPI 1750772752
$7,591.06
in general payments reported to CMS, 2019-2025
13 companies · $334 in 2025
The $334 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,576 · 2020: $336 · 2021: $1,748 · 2022: $2,613 · 2023: $399 · 2024: $585 · 2025: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,137 · Education: $181.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,137.15 |
| Education | $180.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $2,579.38 | 2019-2021 | |
| Stryker Corporation | $2,451.95 | 2022-2024 | Restoration, Axsos, Trident |
| Medical Device Business Services, INC. | $709.68 | 2020-2022 | |
| Depuy Synthes Sales INC. | $321.33 | 2019-2023 | Tfn-Advance |
| Integra Lifesciences Corporation | $279.29 | 2022-2023 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Zimmer Biomet Holdings, INC. | $246.60 | 2019-2025 | Avitus Bone Harvester |
| Si-Bone, INC. | $243.39 | 2021-2025 | |
| Foundation Medical, LLC | $222.41 | 2023-2025 | |
| Smith+Nephew, INC. | $187.24 | 2022-2024 | Evos, Maverick |
| Polynovo North America LLC | $127.94 | 2024 | Novosorb Btm |
| Avita Medical Americas, LLC | $106.85 | 2024 | |
| The Orthopaedic Implant Company | $85.00 | 2021 | |
| Osteocentric Technologies, INC. | $30.00 | 2023 | Osteocentric 4.0 X 130mm Locking Bone Screw Fastener St |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kamil Bober listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.